Mascarilla N95 (fm-3)

Información básica

• Disponible en:
• English
• Español

Product Description:

The EarlyTect Colon Cancer Test is a groundbreaking diagnostic tool designed specifically for the detection of colorectal cancer (CRC). This product has undergone rigorous clinical trials at renowned medical facilities such as Yonsei Medical Center, Severance Hospital, and Severance Check-up Center. The Korea Ministry of Food and Drug Safety has granted approval for this test, further solidifying its reliability and effectiveness.

Utilizing fecal DNA samples, the EarlyTect Colon Cancer Test has demonstrated an impressive 90% sensitivity and specificity in diagnosing CRC. By measuring the levels of methylated Syndecan-2, a clinically significant biomarker associated with precancerous lesions of CRC, this qualitative real-time PCR test provides accurate and early detection of colorectal cancer.

It is important to note that the EarlyTect Colon Cancer Test is not intended to exclusively confirm the presence of colorectal cancer. If a subject tests positive, it indicates the potential existence of CRC or precancerous lesions of CRC. Further medical examination and analysis are required to obtain a definitive diagnosis.

Product Standard:

- Cancer Type: Colorectal Cancer
- Subject: Asymptomatic individuals undergoing colorectal cancer screening
- Biomarker: SDC2 methylation

The price and transaction conditions for the EarlyTect Colon Cancer Test are negotiable. To obtain more information and initiate a transaction, please submit a quote request.